Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

DigiFab approved in Canada to treat digoxin toxicity/overdose

Feb. 1, 2011

CBLB-502 demonstrates direct anticancer effect in preclinical models

Jan. 24, 2011

RiVax receives FDA orphan drug status for prevention of ricin intoxication

Jan. 24, 2011

Histamine H3 receptor antagonist JNJ-39220675 shows promise against alcoholism

Jan. 21, 2011

FDA approves new formulation of acetylcysteine injection

Jan. 18, 2011

New cannabinoid CB1 receptor antagonists presented by sanofi-aventis

Jan. 13, 2011

Anticocaine vaccine dAd5GNC shows promise in mice

Jan. 11, 2011

Lundbeck completes two phase III trials of nalmefene for alcohol dependence

Jan. 3, 2011

Preliminary phase Ib/IIa data presented on ibudilast in opioid addiction

Dec. 15, 2010

Orexo's new sublingual tablet formulation of buprenorphine/naloxone completes phase I trial

Dec. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...